No products in the cart.
This image is AI generated. Original product image may vary.
Voglibose 0.2 mg + Repaglinide 1 mg I.P. tablets are a combination anti-diabetic medicine for Type 2 diabetes, controlling blood sugar spikes after meals by increasing insulin release (Repaglinide) and slowing sugar absorption (Voglibose), requiring diet/exercise and often causing low blood sugar, gas, or diarrhea, needing doctor guidance for proper use and managing side effects.
What it is
- A prescription medication combining two anti-diabetic drugs: Repaglinide (1mg) and Voglibose (0.2mg).
- Belongs to the class of anti-diabetic agents, specifically for managing Type 2 Diabetes Mellitus.
How it works (Mechanism of Action)
- Repaglinide: Stimulates the pancreas to release more insulin when you eat, helping lower blood sugar.
- Voglibose: Slows down the breakdown of complex carbohydrates into simple sugars in your gut, reducing the rapid rise in blood sugar after meals (post-meal spikes).
Uses
- To control high blood glucose (sugar) levels in Type 2 Diabetes.
- Specifically targets and lowers blood sugar levels that rise after eating.
- Used when diet, exercise, and other single medications aren’t enough.
Important Considerations
- Lifestyle: Must be used with a healthy diet and regular exercise for best results.
- Timing: Voglibose should be taken just before meals because it affects post-meal sugar.
- Side Effects: Can include low blood sugar (hypoglycemia), stomach pain, diarrhea, flatulence, nausea, vomiting.
- Cautions: Inform your doctor about bowel issues (obstruction risk) or pregnancy/breastfeeding.
- Not a Cure: Manages diabetes; doesn’t cure it, but reduces long-term complications (kidney, eye, nerve damage).
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.
-
(0 customer reviews)